Summary

KEY FINDINGS
The Europe insulin patch pumps market is expected to grow with a CAGR of 10.08% during the forecasting years of 2023 to 2032. The market growth of the region is promoted by factors such as the rising prevalence of diabetes, the increase in international research collaborations on technological advancements, as well as the growing awareness about diabetes.
MARKET INSIGHTS
The Europe insulin patch pumps market growth analysis includes the evaluation of the United Kingdom, Germany, France, Italy, Switzerland, Spain, Poland, and Rest of Europe. As per the IDF Diabetes Atlas 2021, overall diabetes-related health expenditure in Spain among adults was $15.5 billion in the year 2021. Furthermore, in the same year, the prevalence of diabetes in adults was 14.8%, with around 20% of the country’s population aged 65 years and above.
On the other hand, as per the International Diabetes Federation (IDF), Switzerland had one of the highest diabetes-related annual expenditures per person in the year 2021, equating to about $12,828. The country also recorded a diabetes prevalence of approximately 6% in adults between the age of 20 to 79. Additionally, the population aged 65 years and over in Switzerland was more than 19% in 2022. Since the growing geriatric population is associated with a high risk of diabetes, this factor is set to play an essential role in boosting the insulin patch pumps market growth in Europe during the projection period.
COMPETITIVE INSIGHTS
Key companies operating in the market are Cequr SA, Debiotech SA, F.Hoffmann-La Roche Ltd, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.5. MAJOR MARKET FINDINGS
2.5.1. RISING OCCURRENCE OF DIABETES
2.5.2. GROWING HEALTHCARE AWARENESS
2.5.3. TECHNOLOGICAL ADVANCEMENTS IN INSULIN DELIVERY SYSTEMS
2.5.4. INCREASING RESEARCH AND DEVELOPMENT IN MEDICAL DEVICES
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. GROWING PREVALENCE OF DIABETES
3.1.2. TECHNOLOGICAL ADVANCEMENTS IN INSULIN PATCH PUMPS
3.1.3. RISING AWARENESS ABOUT PATCH PUMPS
3.2. KEY RESTRAINTS
3.2.1. STRINGENT GOVERNMENT REGULATIONS
3.2.2. RISKS ASSOCIATED WITH THE USE OF PUMPS
3.2.3. LACK OF KNOWLEDGE LIMITS THE ADOPTION
4. KEY ANALYTICS
4.1. PARENT MARKET ANALYSIS
4.2. KEY TECHNOLOGY TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. GROWTH PROSPECT MAPPING
4.5. MARKET MATURITY ANALYSIS
4.6. MARKET CONCENTRATION ANALYSIS
4.7. VALUE CHAIN ANALYSIS
4.7.1. RESEARCH AND DEVELOPMENT
4.7.2. PRODUCT MANUFACTURING
4.7.3. SALES AND DISTRIBUTION
4.8. KEY BUYING CRITERIA
4.8.1. COST
4.8.2. PRODUCT FEATURES
4.8.3. USABILITY
5. MARKET BY TYPE
5.1. DISPOSABLE
5.2. REUSABLE
6. MARKET BY DELIVERY MODE
6.1. BASAL
6.2. BOLUS
6.3. BASAL & BOLUS
7. MARKET BY DISEASE INDICATION
7.1. TYPE 1 DIABETES
7.2. TYPE 2 DIABETES
8. MARKET BY DISTRIBUTION CHANNEL
8.1. HOSPITAL PHARMACIES
8.2. RETAIL PHARMACIES
8.3. ONLINE PHARMACIES
9. GEOGRAPHICAL ANALYSIS
9.1. EUROPE
9.1.1. MARKET SIZE & ESTIMATES
9.1.2. EUROPE INSULIN PATCH PUMPS MARKET DRIVERS
9.1.3. EUROPE INSULIN PATCH PUMPS MARKET CHALLENGES
9.1.4. EUROPE INSULIN PATCH PUMPS MARKET REGULATORY FRAMEWORK
9.1.5. KEY PLAYERS IN EUROPE INSULIN PATCH PUMPS MARKET
9.1.6. COUNTRY ANALYSIS
9.1.6.1. UNITED KINGDOM
9.1.6.1.1. UNITED KINGDOM INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.1.6.2. GERMANY
9.1.6.2.1. GERMANY INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.1.6.3. FRANCE
9.1.6.3.1. FRANCE INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.1.6.4. ITALY
9.1.6.4.1. ITALY INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.1.6.5. SPAIN
9.1.6.5.1. SPAIN INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.1.6.6. SWITZERLAND
9.1.6.6.1. SWITZERLAND INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.1.6.7. POLAND
9.1.6.7.1. POLAND INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.1.6.8. REST OF EUROPE
9.1.6.8.1. REST OF EUROPE INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
10. COMPETITIVE LANDSCAPE
10.1. KEY STRATEGIC DEVELOPMENTS
10.1.1. ACQUISITIONS
10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
10.1.3. PARTNERSHIPS & AGREEMENTS
10.2. COMPANY PROFILES
10.2.1. CEQUR SA
10.2.1.1. COMPANY OVERVIEW
10.2.1.2. PRODUCTS / SERVICES LIST
10.2.1.3. STRENGTHS & CHALLENGES
10.2.2. DEBIOTECH SA
10.2.2.1. COMPANY OVERVIEW
10.2.2.2. PRODUCTS / SERVICES LIST
10.2.2.3. STRENGTHS & CHALLENGES
10.2.3. EOFLOW CO LTD
10.2.3.1. COMPANY OVERVIEW
10.2.3.2. PRODUCTS / SERVICES LIST
10.2.3.3. STRENGTHS & CHALLENGES
10.2.4. F. HOFFMANN-LA ROCHE LTD
10.2.4.1. COMPANY OVERVIEW
10.2.4.2. PRODUCTS / SERVICES LIST
10.2.4.3. STRENGTHS & CHALLENGES
10.2.5. INSULET CORPORATION
10.2.5.1. COMPANY OVERVIEW
10.2.5.2. PRODUCTS / SERVICES LIST
10.2.5.3. STRENGTHS & CHALLENGES
10.2.6. MEDTRONIC PLC
10.2.6.1. COMPANY OVERVIEW
10.2.6.2. PRODUCTS / SERVICES LIST
10.2.6.3. STRENGTHS & CHALLENGES
10.2.7. MEDTRUM TECHNOLOGIES INC
10.2.7.1. COMPANY OVERVIEW
10.2.7.2. PRODUCTS / SERVICES LIST
10.2.7.3. STRENGTHS & CHALLENGES
10.2.8. TANDEM DIABETES CARE INC
10.2.8.1. COMPANY OVERVIEW
10.2.8.2. PRODUCTS / SERVICES LIST
10.2.8.3. STRENGTHS & CHALLENGES
10.2.9. TERUMO CORPORATION
10.2.9.1. COMPANY OVERVIEW
10.2.9.2. PRODUCTS / SERVICES LIST
10.2.9.3. STRENGTHS & CHALLENGES